Skip to content

Accuracy and safety of endoscopic ultrasound guided portal pressure gradient measurement in cirrhotic patients with portal hypertension

Accuracy and safety of endoscopic ultrasound guided portal pressure gradient measurement in cirrhotic patients with portal hypertension

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096094
Enrollment
Unknown
Registered
2025-01-17
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhotic portal hypertension

Interventions

Gold Standard:Hepatic venous pressure gradient(HVPG)
Index test:Endoscopic ultrasound-guided portal pressure gradient(EUS-PPG)

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75 years; 2. Cirrhosis due to various causes, the presence of portal hypertension is suggested by clinical manifestations (e.g., presence of ascites, esophagogastric varices) or by noninvasive methods (e.g., elastosonographic liver stiffness measurement) or invasive methods (HVPG measurement); 3. With complete information; 4. Informed consent was obtained to participate in the study;

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary function disorders could not tolerate EUS puncture pressure measurement and interventional procedures; 2. Abnormal coagulation index, international normalized ratio (INR) >1.5 or platelet count <50×109/L, puncture has a high risk of bleeding; 3. Patients who had previously undergone transjugular intrahepatic portosystemic shunt (TIPS); 4. Preoperative anesthesia evaluation was performed routinely, and the results of anesthesia evaluation were those who were not suitable for examination or treatment under general anesthesia; 5. Refusal to participate in this study;

Design outcomes

Primary

MeasureTime frame
Consistency between EUS-PPG measurements and HVPG measurements;

Secondary

MeasureTime frame
Incidence of complication;

Countries

China

Contacts

Public ContactBin Zhou

Peking University First Hospital

byzhoubin@163.com+86 10 83572437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026